Search for: "Eli Lilly & Co." Results 501 - 520 of 1,009
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Sep 2011, 5:57 pm
Eli Lilly and Co. spent the most on speakers, $61.5 million, and had about half the sales of Pfizer. [read post]
14 Sep 2011, 8:21 am by Bexis
Eli Lilly & Co., 99 F.R.D. 126, 128 (D.D.C. 1983).Notwithstanding that informal interviews are permissible, a DC plaintiff attorney wanted to order his client’s treater not to speak to defense counsel (even if the doctor wanted to). [read post]
7 Sep 2011, 8:07 am by admin
Drugmaker Eli Lilly unsuccessfully brought a similar action in South Carolina a few years ago. [read post]
26 Aug 2011, 7:28 am by Bexis
Eli Lilly & Co., ___ F.3d ___, 2011 WL 3625105, slip op. (2d Cir. [read post]
22 Aug 2011, 2:00 am by Stefanie Levine
Eli Lilly and Company, 598 F.3d 1336, 1340 (2010). [read post]
22 Aug 2011, 2:00 am by Stefanie Levine
Eli Lilly and Company, 598 F.3d 1336, 1340 (2010). [read post]
16 Aug 2011, 11:35 pm by Marie Louise
PTO does not appear to invalidate very many gene patent method claims (Holman’s Biotech IP Blog) US: Machine-or-transformation test after Myriad: Implications to the prosecution of process claims (Patent Law Practice Center) US: Unsuccessful Qui Tam plaintiff asserting false marking claim not immune from costs award: Promote Innovation v Roche Diagnostics (Docket Report) US: FDA releases two medical device draft guidances (FDA Law Blog) US: BIO: Unleashing the promise of biotechnology (pt.4)… [read post]
10 Aug 2011, 9:59 pm by Patent Docs
USPTO (the Myriad case), the Court also handed down its opinion in Eli Lilly & Co. v. [read post]
9 Aug 2011, 8:38 pm by Eric Schweibenz
  In the Order, ALJ Rogers granted-in-part and denied-in-part Complainant Eli Lilly and Company’s (“Lilly”) motion for a presumption of infringement under 35 U.S.C. [read post]
9 Aug 2011, 8:24 pm by Eric Schweibenz
’s (collectively, “Teva”) motion to quash and/or limit the subpoenas duces tecum and ad testificandum issued upon application of Complainant Eli Lilly and Company (“Lilly”). [read post]
8 Aug 2011, 12:53 pm by info@thomasjhenrylaw.com
Violations of this act have led to multi-million dollar settlements with other pharmaceutical giants like Eli Lilly and Co. and Pfizer Inc. in the past. [read post]
1 Aug 2011, 8:19 am
According to the Indianapolis Business Journal, the drug generated $577 million in sales for Lilly last year.The case is Eli Lilly & Co. v. [read post]